Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High levels of circulating TNFR1 increase the risk of all-cause mortality and progression of renal disease in type 2 diabetic nephropathy.
Fernández-Juárez G, Villacorta Perez J, Luño Fernández JL, Martinez-Martinez E, Cachofeiro V, Barrio Lucia V, Tato Ribera AM, Mendez Abreu A, Cordon A, Oliva Dominguez JA, Praga Terente M. Fernández-Juárez G, et al. Nephrology (Carlton). 2017 May;22(5):354-360. doi: 10.1111/nep.12781. Nephrology (Carlton). 2017. PMID: 27003829 Clinical Trial.
Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: a randomized trial.
Fernandez Juarez G, Luño J, Barrio V, de Vinuesa SG, Praga M, Goicoechea M, Cachofeiro V, Nieto J, Fernández Vega F, Tato A, Gutierrez E; PRONEDI Study Group. Fernandez Juarez G, et al. Am J Kidney Dis. 2013 Feb;61(2):211-8. doi: 10.1053/j.ajkd.2012.07.011. Epub 2012 Aug 29. Am J Kidney Dis. 2013. PMID: 22939518 Clinical Trial.
25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
Fernández-Juárez G, Luño J, Barrio V, de Vinuesa SG, Praga M, Goicoechea M, Lahera V, Casas L, Oliva J; PRONEDI Study Group. Fernández-Juárez G, et al. Clin J Am Soc Nephrol. 2013 Nov;8(11):1870-6. doi: 10.2215/CJN.00910113. Epub 2013 Oct 17. Clin J Am Soc Nephrol. 2013. PMID: 24135218 Free PMC article. Clinical Trial.
Acute oxalate nephropathy and chronic pancreatitis.
Escudero-Sánchez R, Villacorta-Pérez J, Fernández-Juarez GM, Guerrero-Márquez MC, Fernández Gil M. Escudero-Sánchez R, et al. Rev Clin Esp (Barc). 2015 Aug-Sep;215(6):352-4. doi: 10.1016/j.rce.2015.02.011. Epub 2015 Mar 18. Rev Clin Esp (Barc). 2015. PMID: 25796468 English, Spanish. No abstract available.
Kidney injury after sodium phosphate solution beyond the acute renal failure.
Fernández-Juárez G, Parejo L, Villacorta J, Tato A, Cazar R, Guerrero C, Marin IM, Ocaña J, Mendez-Abreu A, López K, Gruss E, Gallego E. Fernández-Juárez G, et al. Nefrologia. 2016 May-Jun;36(3):243-8. doi: 10.1016/j.nefro.2016.02.010. Epub 2016 Apr 15. Nefrologia. 2016. PMID: 27087365 Free article. English, Spanish.
Renal vasculitis presenting with acute kidney injury.
Villacorta J, Diaz-Crespo F, Acevedo M, Cavero T, Guerrero C, Praga M, Fernandez-Juarez G. Villacorta J, et al. Rheumatol Int. 2017 Jun;37(6):1035-1041. doi: 10.1007/s00296-017-3697-2. Epub 2017 Mar 13. Rheumatol Int. 2017. PMID: 28289874
Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).
Goicoechea M, de Vinuesa SG, Quiroga B, Verde E, Bernis C, Morales E, Fernández-Juárez G, de Sequera P, Verdalles U, Delgado R, Torres A, Arroyo D, Abad S, Ortiz A, Luño J. Goicoechea M, et al. Cardiovasc Drugs Ther. 2018 Jun;32(3):255-263. doi: 10.1007/s10557-018-6802-1. Cardiovasc Drugs Ther. 2018. PMID: 29943364 Clinical Trial.
93 results